Literature DB >> 9086160

Levels of human immunodeficiency virus type 1 RNA in cerebrospinal fluid correlate with AIDS dementia stage.

B J Brew1, L Pemberton, P Cunningham, M G Law.   

Abstract

The relationship between the presence and severity of AIDS dementia complex (ADC) and the levels of human immunodeficiency virus type 1 (HIV-1) RNA in cerebrospinal fluid (CSF) were assessed. Nineteen patients with ADC (stages 1-3), 6 without ADC (group 1), and 10 (group 2) without ADC but with cryptococcal meningitis or progressive multifocal leukoencephalopathy were studied. There was a significant relationship between increasing CSF virus burden and ADC severity (P = .0006) but not with plasma burden and ADC severity. In group 2, CSF HIV-1 RNA levels in patients with cryptococcal meningitis were elevated. These results show that CSF HIV-1 RNA concentrations correlate well with ADC severity but may also be increased by central nervous system infections, such as cryptococcal meningitis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9086160     DOI: 10.1086/514001

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  70 in total

1.  HIV and HIV dementia.

Authors:  D L Kolson; F González-Scarano
Journal:  J Clin Invest       Date:  2000-07       Impact factor: 14.808

Review 2.  Human immunodeficiency virus-associated dementia: an evolving disease.

Authors:  Justin C McArthur; Norman Haughey; Suzanne Gartner; Kathy Conant; Carlos Pardo; Avi Nath; Ned Sacktor
Journal:  J Neurovirol       Date:  2003-04       Impact factor: 2.643

3.  New Thoughts on Pathogenesis and Diagnosis of Encephalitis.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  1999-06       Impact factor: 3.725

Review 4.  Thinking about HIV: the intersection of virus, neuroinflammation and cognitive dysfunction.

Authors:  K Grovit-Ferbas; M E Harris-White
Journal:  Immunol Res       Date:  2010-12       Impact factor: 2.829

5.  Motor function and human immunodeficiency virus-associated cognitive impairment in a highly active antiretroviral therapy-era cohort.

Authors:  Jessica Robinson-Papp; Desiree Byrd; Monica Rivera Mindt; Neal Leonard Oden; David M Simpson; Susan Morgello
Journal:  Arch Neurol       Date:  2008-08

Review 6.  Molecular methods for diagnosis of viral encephalitis.

Authors:  Roberta L Debiasi; Kenneth L Tyler
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

Review 7.  Benzodiazepines, glia, and HIV-1 neuropathogenesis.

Authors:  J R Lokensgard; C C Chao; G Gekker; S Hu; P K Peterson
Journal:  Mol Neurobiol       Date:  1998-08       Impact factor: 5.590

Review 8.  Molecular mechanisms of neuroinvasion by monocytes-macrophages in HIV-1 infection.

Authors:  Gabriel Gras; Marcus Kaul
Journal:  Retrovirology       Date:  2010-04-07       Impact factor: 4.602

9.  Cerebrospinal fluid neopterin: an informative biomarker of central nervous system immune activation in HIV-1 infection.

Authors:  Lars Hagberg; Paola Cinque; Magnus Gisslen; Bruce J Brew; Serena Spudich; Arabella Bestetti; Richard W Price; Dietmar Fuchs
Journal:  AIDS Res Ther       Date:  2010-06-03       Impact factor: 2.250

10.  Variables that influence HIV-1 cerebrospinal fluid viral load in cryptococcal meningitis: a linear regression analysis.

Authors:  Diego M Cecchini; Ana M Cañizal; Haroldo Rojas; Alicia Arechavala; Ricardo Negroni; María B Bouzas; Jorge A Benetucci
Journal:  J Int AIDS Soc       Date:  2009-11-11       Impact factor: 5.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.